Figure 5.
Figure 5. Inhibition of inflammatory reactions in vivo by angiostatin. Following thioglycollate injection into the mouse peritoneum to induce acute inflammation, the number of neutrophils in the peritoneal lavage was analyzed after 4 hours: (A) Prior to thioglycollate administration, separate mice were treated by intraperitoneal injection with PBS-buffer only (▦; –), with a blocking mAb against Mac-1, or with a blocking mAb against LFA-1 or recombinant angiostatin (K1-4) (each 100 μg) as indicated. *P < .001 compared with control (only buffer). (B) Prior to thioglycollate administration, separate mice were treated by intraperitoneal injection with PBS buffer (▦) , with K1-4, K1-3, or K4 (▪ 100 μg; □ 40 μg). *P < .001; #P < .05; ns indicates not significant, compared with control (only buffer). Data are mean ± SD (n = 8-10 mice per treatment).

Inhibition of inflammatory reactions in vivo by angiostatin. Following thioglycollate injection into the mouse peritoneum to induce acute inflammation, the number of neutrophils in the peritoneal lavage was analyzed after 4 hours: (A) Prior to thioglycollate administration, separate mice were treated by intraperitoneal injection with PBS-buffer only (▦; –), with a blocking mAb against Mac-1, or with a blocking mAb against LFA-1 or recombinant angiostatin (K1-4) (each 100 μg) as indicated. *P < .001 compared with control (only buffer). (B) Prior to thioglycollate administration, separate mice were treated by intraperitoneal injection with PBS buffer (▦) , with K1-4, K1-3, or K4 (▪ 100 μg; □ 40 μg). *P < .001; #P < .05; ns indicates not significant, compared with control (only buffer). Data are mean ± SD (n = 8-10 mice per treatment).

Close Modal

or Create an Account

Close Modal
Close Modal